About Alume Biosciences
Alume Biosciences is a private company based in LA Jolla, California. It has reported $35,545,278 raised in six offerings on Form D since July 2019. Its chief executive is Quyen Nguyen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Apr 6, 2026amended May 8, 2026 | $2,160,000of $8.0M target | 4 | $540K | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 30, 2025 | Oct 31, 2025amended Feb 19, 2026 | $6,853,305of $23.4M target | 92 | $74,492 | EquityRule 506(b) | Form D/A ↗4 earlier filings |
| Dec 28, 2022 | Jan 9, 2023 | $12,759,950of $45.0M target | 43 | $296K | Equity, OptionsRule 506(b) | Form D ↗ |
| Apr 1, 2022 | Apr 15, 2022amended Sep 21, 2022 | $4,000,000of $5.2M target | 26 | $153K | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 21, 2020 | Aug 26, 2020 | $4,000,000fully sold | 34 | $117K | EquityRule 506(b) | Form D ↗ |
| Jun 28, 2019 | Jul 11, 2019 | $5,772,023of $8.5M target | 40 | $144K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $35,545,278 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alume Biosciences's Form D filed May 8, 2026.
Earlier filings also listed Jean-Pierre Million (director, last listed Aug 2020).
Sources
- SECAlume Biosciences Inc Form D, filed Apr 6, 2026
- SECAlume Biosciences Inc Form D/A, filed Jan 30, 2026
- SECAlume Biosciences Inc Form D/A, filed Dec 31, 2025
- SECAlume Biosciences Inc Form D/A, filed Nov 12, 2025
- SECAlume Biosciences Inc Form D, filed Oct 31, 2025
- SECAlume Biosciences Inc Form D, filed Apr 15, 2022
- SECAlume Biosciences Inc filing history
- CompanyAbout Alume Biosciences
- CompanyFDA Fast Track designation announcement